Izotropic Corp. · CSE:IZO
Izotropic — Investor Presentation (March 2021)
20 slides from Izotropic's investor presentation, Mar 22, 2021
Slide 1: Investor Presentation March 2021
INVESTOR PRESENTATION MARCH 2021 Gizoview
Slide 2: Izotropic Corporation
IZOTROPIC CORPORATION BREAST CT EVOLUTION GROWING MARKET ¢ $20M spent on R&D to date ¢ Breast imaging market growing from ¢ Performing prototypes and $3.7B to $5.4B by 2025 ongoing clinical trials « Imaging and diagnostic procedure ¢ Published journal articles costs after screening mammography ¢ Pro
Slide 3: Licensed Technology & Intellectual Property
LICENSED TECHNOLOGY & INTELLECTUAL PROPERTY GLOBAL LICENSING RIGHTS * Exclusive worldwide licensing rights to Breast CT through an agreement with The Regents of The University of California * Developed over 20 years by principal technology \ founder and company director Dr. John M. Boone * Commercia
Slide 4: True 3D Breast CT Imaging
TRUE 3D BREAST CT IMAGING
Slide 5: U.S. Breast Cancer Landscape
U.S. BREAST CANCER LANDSCAPE 41M BREASTS SCANS IN 2019 280K NEW BREAST CANCER CASES / * Screening mammography misses 1/5 cancers 1 in 8 women will be diagnosed with breast ¢ Breast cancer is now the most common form cancer in their lifetime, 1 in 39 will die oie eliseets ayesone : ¢ Estimated 43,600
Slide 6: Diagnostic Mammography Challenges
DIAGNOSTIC MAMMOGRAPHY CHALLENGES te BREAST COMPRESSION ¢ Distorted imaging, patient discomfort, can obscure lesions and tumors * Poor contrast uptake and visualization with compression PATIENT DIGNITY LOSS * Considerable breast handling by technician 2D IMAGING LIMITATIONS © 1 degree view with mamm
Slide 7: IzoView Breast CT
IZOVIEW BREAST CT A whole new experience for patients, radiologists and providers. Gizoview a For illustrative purposes only. Not yet approved for sale NO BREAST COMPRESSION Natural breast orientation preserved, no pain or discomfort, very comfortable face down view, excellent visualization with con
Slide 8: Contrast-Enhanced Breast CT detection comparison
trast-Enhanced Breast CT than both mammography Gizoview True 3D, 360 degree 1 breast CT image slice 3-5 mm avg. detection size of the 500 obtained CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 8
Slide 9: IzoView Platform Uses
IZOVIEW PLATFORM USES Making Breast CT an indispensable tool for improving the outcomes of br SCREENING DIAGNOSTIC BIOPSY TREATMENT £™ ———__ "ae NEW INDICATIONS CURRENT REGULATORY NEW ACCESSORIES FOCUS NEW DEVICES _NEW SOFTWARE ji CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 9
Slide 10: Market Acceptance
MARKET ACCEPTANCE Customers are asking for IZOVIEW today. RADIOLOGISTS ° Superior image quality « Assessment of breast density & micro-calcifications ¢ True 3D images to rotate PATIENTS ¢ Comfort ¢ Dignity ¢ Speed - 10 seconds PROVIDORS ¢ x3 Patient throughput ¢ Limited training required ¢ Competiti
Slide 11: Commercial Development Pathway
COMMERCIAL DEVELOPMENT PATHWAY ey PROOF OF RESEARCH & ACADEMIC READY TO CONCEPT PROTOTYPES CLINICAL TRIALS COMMERCIALIZE COMMERCIAL COMMERCIAL CLINICAL CLINICAL REGULATORY DESIGN PROTOTYPE DEVICE STUDY SUBMISSION la WY * Design final device and * Hardware and software * Complete izoview build * Deli
Slide 12: Current Work Stream Activities
CURRENT WORK STREAM ACTIVITIES Instigating multiple programs to increase speed to market. DEVELOPMENT REIMBURSEMENT REGULATORY ¢ Al software modules and hardware * Expanding payor engagement ¢ Discussions with juri: accessories to expand izoview platform ¢ Collaborating with payors on outside of U.S
Slide 13: Directors & Management
DIRECTORS & MANAGEMENT JOHN MCGRAW, PHD JOHN M. BOONE, PHD CEO & Director Founder & Director Executive in imaging, diagnostic Medical Physicist, Professor, service, and medical device public global speaker, text book companies author, ICRU Commissioner BOB THAST Director & Special Advisor Capital ma
Slide 14: Dr. John Boone
DR. JOHN BOONE Principal Founder of Breast CT Technology & Director "We scanned the first patient using cone beam breast CT in 2004, scanned the first cancer patient in early 2005, and performed the first contrast - enhanced breast CT exam in 2006. | take my cues from the breast imaging radiologists
Slide 15: Dr. John McGraw
DR. JOHN MCGRAW Chief Executive Officer (Effective April 5, 2021) "High resolution breast imaging is critical to identifying malignancies as early as possible. Izotropic’s Breast CT has the opportunity to offer patients, with or without dense breasts, a single rapid scan for breast cancer detection
Slide 16: Medical & Scientific Advisors
MEDICAL & SCIENTIFIC ADVISORS Internationally Recognized Specialists DR. MARTIN YAFFE PHD Drove the development of digital mammography , Member of The Order of Canada GEORGE BURKETT M.ENG Responsible for the detailed design, mechanical and hardware development of breast CT at UC Davis CSE: 1ZO OTCQB
Slide 17: Market Capitalization
MARKET CAPITALIZATION March 22, 2021 52 WEEK RANGE - CSE: CAD $0.115 - 1.56 52 WEEK RANGE - OTC: US $0.0814 - 1.23 52 WEEK RANGE - FSE: EUR $0.060 - 0.95 COMMON SHARES ISSUED - BASIC: 41,658,078 WARRANTS: 6,200,000 @ $0.20 WARRANTS: 6,883,400 @ $0.75 WARRANTS: 1,896,679 @ $1.50 BROKER WARRANTS: 193,
Slide 18: Legal
LEGAL SECURITIES COUNSEL: CLARK WILSON LLP https://www.cwilson.com TRUST AGENT: ODYSSEY TRUST https://odysseytrust.com U.S. PATENT COUNSEL: VENABLE LLP https://www.venable.com REGULATORY COUNSEL: BROOKE CONSULTING LLC https://www.brooke-consulting.com CSE: 1ZO OTCQB: IZOZF BREAST CT IMAGING - 18
Slide 19: Citations
CITATIONS 1, Breast CT Scanner For Earlier Cancer Detection https://ucdavis.pure.elsevier.com/en/projects/breas t-ct-scanner-for-earlier-cancer-detection 2.-BMJs"Every month delayed in cancer treatment can raise risk of death by around 10%." ScienceDaily. ScienceDaily, 4 November 2020 <www.scienceda
Slide 20: Investor Relations
INVESTOR RELATIONS: IR@izocorp.com 1-833-IZOCORP ext.1 Gizoview GENERAL INQUIRIES info@izocorp.com 1-833-IZOCORP ext. 2 izocorp.com VW aizotropic EPeizorropic fH @izotropic BREAST CT IMAGING - 20